Literature DB >> 21091434

Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells.

Fan Feng1, Jianjun Yang, Liping Tong, Shifa Yuan, Yangzi Tian, Liu Hong, Weizhong Wang, Hongwei Zhang.   

Abstract

Tachykinins such as SP (substance P) may be involved in the progression of gastric adenocarcinoma through binding to NK-1 receptor. However, the existence and relationship between SP and gastric cancer progression and differentiation remained unknown. We have studied the NK-1 receptor in human gastric cancer tissue and MKN45 cell line and found SP-containing nerve fibres in human gastric cancer and found that the amounts of SP-positive nerves were related to gastric cancer differentiation. SP could promote proliferation, adhesion, migration and invasion of MKN45 cells in vitro. In addition, the intracellular calcium level of MKN45 cells was elevated after SP stimulation, and administration of CRACs (calcium release-activated calcium channels) inhibitor SKF-96365 could partially abolish these effects induced by SP. These results demonstrated that NK-1 receptor and SP-containing nerves existed in human gastric cancer; SP positive nerves may play an important role in human gastric cancer progression, and calcium is critically significant among SP-induced biological effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21091434     DOI: 10.1042/CBI20100229

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  18 in total

Review 1.  Involvement of substance P and the NK-1 receptor in pancreatic cancer.

Authors:  Miguel Muñoz; Rafael Coveñas
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

2.  Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.

Authors:  Fanyin Meng; Sharon DeMorrow; Julie Venter; Gabriel Frampton; Yuyan Han; Heather Francis; Holly Standeford; Shanika Avila; Kelly McDaniel; Matthew McMillin; Syeda Afroze; Micheleine Guerrier; Morgan Quezada; Debolina Ray; Lindsey Kennedy; Laura Hargrove; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-03-06       Impact factor: 4.052

Review 3.  The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.

Authors:  Miguel Munoz; Rafael Covenas; Francisco Esteban; Maximino Redondo
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

4.  Design, Synthesis, and Evaluation of a Neurokinin-1 Receptor-Targeted Near-IR Dye for Fluorescence-Guided Surgery of Neuroendocrine Cancers.

Authors:  Ananda Kumar Kanduluru; Madduri Srinivasarao; Philip S Low
Journal:  Bioconjug Chem       Date:  2016-09-02       Impact factor: 4.774

Review 5.  The neurobiology of cancer pain.

Authors:  Brian L Schmidt
Journal:  Neuroscientist       Date:  2014-03-24       Impact factor: 7.519

Review 6.  Targeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic Approach.

Authors:  Miguel Muñoz; Rafael Coveñas
Journal:  Cancers (Basel)       Date:  2015-07-06       Impact factor: 6.639

7.  Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance.

Authors:  Prema Robinson; Moses Kasembeli; Uddalak Bharadwaj; Nikita Engineer; Kris T Eckols; David J Tweardy
Journal:  Biomed Res Int       Date:  2016-02-11       Impact factor: 3.411

8.  Role of the nervous system in cancer metastasis.

Authors:  Sha Li; Yanlai Sun; Dongwei Gao
Journal:  Oncol Lett       Date:  2013-01-31       Impact factor: 2.967

9.  IB4(+) and TRPV1(+) sensory neurons mediate pain but not proliferation in a mouse model of squamous cell carcinoma.

Authors:  Yi Ye; Sam S Bae; Chi T Viet; Scott Troob; Daniel Bernabé; Brian L Schmidt
Journal:  Behav Brain Funct       Date:  2014-02-13       Impact factor: 3.759

10.  High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.

Authors:  Xiao-Yi Chen; Guo-Qing Ru; Ying-Yu Ma; Jun Xie; Wan-Yuan Chen; Hui-Ju Wang; Shi-Bing Wang; Li Li; Ke-Tao Jin; Xiang-Lei He; Xiao-Zhou Mou
Journal:  Onco Targets Ther       Date:  2016-06-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.